Loading data for FTXH — first visit, this takes a few seconds.
First Trust Nasdaq Pharma... (FTXH)
: FTXH
· Real-Time Price · USD
n/a
n/a (n/a)
At close: Invalid Date
First Trust Nasdaq Pharmaceuticals ETF (FTXH) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | NaN |
| Avg. Volume (20D) | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About FTXH
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified....
Industry n/a
Sector n/a
IPO Date Sep 22, 2016
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol FTXH
Financial Performance
In undefined, First Trust Nasdaq Pharmaceuticals ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements